Diacylglycerol acyltransferase inhibitors
US8115011B2 · kind B2 · utility
2Cited by
10References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2008 |
| Grant date | Feb 14, 2012 |
| Priority date | — |
| Expiry date | Sep 5, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.